| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Revenue | $2.71B | -2.0% |
| Cost of Revenue | $1.90B | -5.2% |
| R&D Expense | $24.0M | -4.0% |
| SG&A Expense | $631.0M | -4.7% |
| Operating Income | $120.0M | +30.4% |
| Pre-tax Income | $96.0M | -33.8% |
| Income Tax | $15.0M | -57.1% |
| Net Income | $81.0M | -26.4% |
| EPS (Basic) | $0.94 | -26.6% |
| EPS (Diluted) | $0.91 | -28.9% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Cash & Equivalents | $47.0M | -47.2% |
| Accounts Receivable | $199.0M | -18.4% |
| Inventory | $367.0M | +6.4% |
| Current Assets | $640.0M | -9.3% |
| Total Assets | $1.98B | +5.0% |
| Current Liabilities | $851.0M | +1.8% |
| Long-term Debt | $460.0M | -5.5% |
| Line Item | 2024-12-28 | Y/Y |
|---|---|---|
| Operating Cash Flow | $107.0M | -74.6% |
| Capital Expenditures | $129.0M | -14.0% |
| Investing Cash Flow | -$129.0M | +11.6% |
| Financing Cash Flow | -$16.0M | +91.5% |
| Free Cash Flow | -$22.0M | -108.1% |
| Stockholders' Equity |
| $328.0M |
| +9.3% |